AGL · agilon health, inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Mar 31, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Mar 31, 2026.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| ACO Model Members | 112,000 | Q2 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | $70M | Q2 2026 | — |
|
|
|||
| Geography Entry Costs | $4M | Q2 2026 | — |
|
|
|||
| Medical Margin | $197M | Q2 2026 | — |
|
|
|||
| Medicare Advantage Members | 437,000 | Q2 2026 | — |
|
|
|||
| Total Members Live on Platform | 549,000 | Q2 2026 | — |
|
|
|||
| Avg. Medicare Advantage Members | 424,000 | Q1 2026 | — |
|
|
|||
| Medical cost trend for Medicare Advantage members | 6.5% | Fiscal Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AGL
this stock
agilon health, inc.
|
$1.56B | — | -2.1% | — | 5.2% |
|
HCA
HCA Healthcare, Inc.
|
$90.30B | -13.0% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.98B | +37.2% | +0.9% | 10.5 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | -1.6% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Mar 31, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AGL | +4.3% | -7.5% | — | +1.2% | — |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +6.3% | -10.8% | — | -0.9% | — |